Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: A meta-analysis

Human Immunology

Volumn 73, Issue 10, 2012, Pages 1055-1059

  Song, Gwan Gyu ^a   Choi, Sung Jae ^a   Ji, Jong Dae ^a   Lee, Young Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; PROTEIN SMALL UBIQUITIN LIKE MODIFIER 4; SUMO PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EUROPE; GENETIC ASSOCIATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 84866399868     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.07.341     Document Type: Article

References (32)

1. Noble J.A., Erlich H.A. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med 2012, 2(1):a007732.
2. Lee H.J., Her S.H., Im Y.S., Won K.Y., Yoo S.H., Kim D.B., et al. Significance of inflammatory markers in diabetic patients with stable coronary artery disease. Korean J Intern Med 2009, 24(3):212.
3. Guo D., Li M., Zhang Y., Yang P., Eckenrode S., Hopkins D., et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004, 36(8):837.
4. Owerbach D., Pina L., Gabbay K.H. A 212-kb region on chromosome 6q25 containing the TAB2 gene is associated with susceptibility to type 1 diabetes. Diabetes 2004, 53(7):1890.
5. Bohren K.M., Nadkarni V., Song J.H., Gabbay K.H., Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 2004, 279(26):27233.
6. Sang Y., Zong W., Liu M., Yan J. Association of SUMO4 M55V polymorphism with type 1 diabetes in Chinese children. J Pediatr Endocrinol Metab 2010, 23(10):1083.
7. Sedimbi S.K., Kanungo A., Shastry A., Park Y., Sanjeevi C.B. No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients. Int J Immunogenet 2007, 34(2):137.
8. Noso S., Ikegami H., Fujisawa T., Kawabata Y., Asano K., Hiromine Y., et al. Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populations. Ann N Y Acad Sci 2006, 1079:41.
9. Tsurumaru M., Kawasaki E., Ida H., Migita K., Moriuchi A., Fukushima K., et al. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. J Clin Endocrinol Metab 2006, 91(8):3138.
10. Noso S., Ikegami H., Fujisawa T., Kawabata Y., Asano K., Hiromine Y., et al. Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes. Diabetes 2005, 54(12):3582.
11. Park Y., Park S., Kang J., Yang S., Kim D. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005, 37(2):112. author reply 112.
12. Smyth D.J., Howson J.M., Lowe C.E., Walker N.M., Lam A.C., Nutland S., et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005, 37(2):110.
13. Sedimbi S.K., Luo X.R., Sanjeevi C.B., Lernmark A., Landin-Olsson M., Arnqvist H., et al. SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients. Genes Immun 2007, 8(6):518.
14. Sedimbi S.K., Shastry A., Park Y., Rumba I., Sanjeevi C.B. Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients. Ann N Y Acad Sci 2006, 1079:273.
15. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 2006, 27(2):157.
16. Lee Y.H., Nath S.K. Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 2005, 118(3-4):434.
17. Nath S.K., Harley J.B., Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 2005, 118(2):225.
18. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629.
19. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56(2):455.
20. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539.
21. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315(7121):1533.
22. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177.
23. Howson J.M., Walker N.M., Smyth D.J., Todd J.A. Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun 2009, 10(Suppl. 1):S74.
24. Podolsky R., Prasad Linga-Reddy M.V., She J.X. Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes. Genes Immun 2009, 10(Suppl. 1):S16.
25. Wagner A.M., Cloos P., Bergholdt R., Eising S., Brorsson C., Stalhut M., et al. Posttranslational protein modifications in type 1 diabetes - genetic studies with PCMT1, the repair enzyme protein isoaspartate methyltransferase (PIMT) encoding gene. Rev Diabet Stud 2008, 5(4):225.
26. Qu H., Bharaj B., Liu X.Q., Curtis J.A., Newhook L.A., Paterson A.D., et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005, 37(2):111.
27. Caputo M., Cerrone G.E., Mazza C., Cedola N., Targovnik H.M., Gustavo D.F. No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes. Immunol Invest 2007, 36(3):259.
28. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33(2):177.
29. Lee Y.H., Rho Y.H., Choi S.J., Ji J.D., Song G.G., Nath S.K., et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology (Oxford) 2007, 46(1):49.
30. Caamano J., Hunter C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 2002, 15(3):414.
31. Zou Y.F., Feng X.L., Tao J.H., Zhu J.M., Pan F.M., Su H., et al. Association of SUMO4 M55V polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Int J Immunogenet 2010, 37(5):345.
32. Li M., Guo D., Isales C.M., Eizirik D.L., Atkinson M., She J.X., et al. SUMO wrestling with type 1 diabetes. J Mol Med (Berl) 2005, 83(7):504.